Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab in Behçet Disease
NCT02648581Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2017
- Primary completion
- May 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ustekinumab in Behçet disease, sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2017; status: completed.
02
Drugs
ustekinumab
03
Conditions
Behçet disease
Beyond the preview
Go deeper on NCT02648581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02648581.